-
-
-
-
-
-
-
FDA places PepGen's FREEDOM2 trial on partial clinical hold
-
-
-
-
-
-
-
PepGen receives US patent for PGN-EDODM1 drug candidate
-
-
-
-
-
-
-
PepGen Inc. (PEPG) Tops Q2 EPS by 11c
-
-
-
-
-
-
-
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
-
-
-
-
-
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
-
-
-
-
-
-
-
ROSEN, A TOP RANKED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
-
-
-
-
-
-
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
-
408,904 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

